4c4i: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 8: Line 8:
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4c4i FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4c4i OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4c4i RCSB], [http://www.ebi.ac.uk/pdbsum/4c4i PDBsum]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4c4i FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4c4i OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4c4i RCSB], [http://www.ebi.ac.uk/pdbsum/4c4i PDBsum]</span></td></tr>
</table>
</table>
== Function ==
[[http://www.uniprot.org/uniprot/TTK_HUMAN TTK_HUMAN]] Phosphorylates proteins on serine, threonine, and tyrosine. Probably associated with cell proliferation. Essential for chromosome alignment by enhancing AURKB activity (via direct CDCA8 phosphorylation) at the centromere, and for the mitotic checkpoint.<ref>PMID:18243099</ref> 
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==

Revision as of 11:03, 25 December 2014

Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1

4c4i, resolution 2.65Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA